Title

Diagnostic Accuracy Of CSF 14-3-3 Protein In Sporadic Creutzfeldt-Jakob Disease

Authoring Organization

Publication Month/Year

October 2, 2012

Last Updated Month/Year

May 16, 2023

Supplemental Implementation Tools

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

To assess the available evidence for the diagnostic accuracy of CSF testing for protein 14-3-3 in patients with suspected sporadic Creutzfeldt-Jakob disease (sCJD).

Inclusion Criteria

Female, Male, Adult, Older adult

Health Care Settings

Ambulatory, Hospice, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Assessment and screening, Diagnosis, Management

Diseases/Conditions (MeSH)

D007562 - Creutzfeldt-Jakob Syndrome

Keywords

Creutzfeldt-Jakob disease, subacute spongiform encephalopathy, CJD

Source Citation

Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Taim Muayqil, Gary Gronseth, Richard Camicioli. Neurology Oct 2012, 79 (14) 1499-1506; DOI: 10.1212/WNL.0b013e31826d5fc3
 

Supplemental Methodology Resources

Data Supplement, Evidence Tables

Methodology

Number of Source Documents
34
Literature Search Start Date
January 1, 1995
Literature Search End Date
January 1, 2011